Home > News


Researchers develop drug-targeting molecules to improve cancer treatment

nwelding • Date: June 12, 2019

Researchers from the University of Notre Dame have developed small drug-targeting molecules that may be hundreds to thousands of times more effective at delivering potent drugs to desired sites of disease, including cancer.

>Full Story

Notre Dame researchers to tackle autism, preeclampsia and more through new funding

nwelding • Date: September 7, 2018

Nine faculty from the University of Notre Dame have received awards for five projects from the Advanced Diagnostics and Therapeutics’ Discovery Fund. Each year, grants from the Discovery Fund are awarded to researchers who propose novel technologies and diagnostics that can improve human and environmental health.

>Full Story

Leiva Graduate Fellowship in Precision Medicine Awarded to Bioengineering Graduate Student

nwelding • Date: June 14, 2018

Kimberly Curtis, a bioengineering graduate student, has received the Leiva Graduate Fellowship in Precision Medicine.

>Full Story

Professor Gang Bao presents seminar April 26, 2018

ndavis • Date: April 18, 2018

Prof. Gang Bao

Seminar title: "Nanomedicine and Genome Editing Approaches for Disease Therapies" Abstract excerpt: The integration of biomolecular engineering, nanotechnology and biology is expected to produce major breakthroughs in medical diagnostics and therapeutics. Due to the size-compatibility of nano-scale structures with proteins and nucleic acids, the design, synthesis and application of nanoprobes, nanocarriers and nanomachines provide unprecedented opportunities for achieving a better control of biological processes, and drastic improvements in disease detection, therapy, and prevention.

>Full Story

Dr. Mehmet Toner to give Edison Lecture Series seminar April 12, 2018

ndavis • Date: April 5, 2018

Prof. Mehmet Toner

Seminar title: "Extreme Microfluidics" Label-Free Sorting of Extremely Rare Circulating Tumor Cells and Clusters Abstract excerpt: Viable tumor-derived circulating tumor cells (CTCs) have been identified in peripheral blood from cancer patients and are not only the origin of intractable metastatic disease but also marker for early cancer. However, the ability to isolate CTCs has proven to be difficult due to the exceedingly low frequency of CTCs in circulation. As a result, their clinical use until recently has been limited to prognosis with limited clinical utility.

>Full Story